Arrowhead Pharmaceuticals Inc (ARWR)

CapEx to Revenue

5.12%

Quarterly · Period ending:

ARWR logo

ARWR CapEx to Revenue

Latest reported5.12%
ARWR Quarterly CapEx/Revenue (0.00% → 5.12%)
High-resolution chart · PNG

ARWR capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrowhead Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
14.7956%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.